Paul Gregor is an entrepreneur and inventor with expertise in drug discovery, chemical biology and human therapeutics. He received his Ph.D. from the Weizmann Institute of Science (Rehovot, Israel) and was a post-doctoral fellow at the National Institute on Drug Abuse, National Institutes of Health (NIDA/NIH, Baltimore, MD). For his post-doctoral work, Dr. Gregor received a NIDA Special Recognition Award. Dr. Gregor’s industrial experience spans over 20 years in pharmaceutical and biotech companies, including at Bayer Pharmaceuticals Corp. (West Haven, CT), Insight Biopharmaceuticals Ltd. (Israel), and Rimonyx Pharmaceuticals Ltd. (Israel). Dr. Gregor has an established track record in securing investments and grant awards, and in forming and managing industry and academia collaborations.